MEDINDIA
English
हिन्दी
Español
français
中文
Email
Abiraterone
The serum concentration of Lorcaserin can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Aceprometazine.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Lorcaserin.
Acetophenazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Acetophenazine.
Acetyl Sulfisoxazole
The metabolism of Lorcaserin can be decreased when combined with Acetyl sulfisoxazole.
Acetylcholine
The metabolism of Acetylcholine can be decreased when combined with Lorcaserin.
Acetylcholine Chloride
The metabolism of Acetylcholine can be decreased when combined with Lorcaserin.
Ajmaline
The metabolism of Ajmaline can be decreased when combined with Lorcaserin.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Lorcaserin.
Alogliptin
The metabolism of Alogliptin can be decreased when combined with Lorcaserin.
Alosetron
Alosetron may increase the serotonergic activities of Lorcaserin.
Alprenolol
The metabolism of Alprenolol can be decreased when combined with Lorcaserin.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Lorcaserin.
Amiodarone
The metabolism of Lorcaserin can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Lorcaserin.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Lorcaserin.
Amphetamine
The metabolism of Amphetamine can be decreased when combined with Lorcaserin.
Amprenavir
The metabolism of Amprenavir can be decreased when combined with Lorcaserin.
Amsacrine
The metabolism of Amsacrine can be decreased when combined with Lorcaserin.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Lorcaserin.
Apalutamide
The serum concentration of Lorcaserin can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Lorcaserin can be increased when it is combined with Aprepitant.
Aprindine
The metabolism of Aprindine can be decreased when combined with Lorcaserin.
Arformoterol
The metabolism of Arformoterol can be decreased when combined with Lorcaserin.
Aripiprazole
The serum concentration of Aripiprazole can be increased when it is combined with Lorcaserin.
Armodafinil
The metabolism of Lorcaserin can be decreased when combined with Armodafinil.
Artemether
The metabolism of Lorcaserin can be decreased when combined with Artemether.
Asenapine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Asenapine.
Astemizole
The metabolism of Astemizole can be decreased when combined with Lorcaserin.
Asunaprevir
The metabolism of Asunaprevir can be decreased when combined with Lorcaserin.
Atazanavir
The metabolism of Lorcaserin can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Lorcaserin can be decreased when combined with Atomoxetine.
Avanafil
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Avanafil.
Azelastine
The metabolism of Azelastine can be decreased when combined with Lorcaserin.
Azithromycin
The metabolism of Lorcaserin can be decreased when combined with Azithromycin.
Benperidol
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Benperidol.
Benztropine
The metabolism of Benzatropine can be decreased when combined with Lorcaserin.
Benzyl Alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Lorcaserin.
Bepridil
The metabolism of Bepridil can be decreased when combined with Lorcaserin.
Betaxolol
The metabolism of Lorcaserin can be decreased when combined with Betaxolol.
Bisoprolol
The metabolism of Bisoprolol can be decreased when combined with Lorcaserin.
Boceprevir
The metabolism of Lorcaserin can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Lorcaserin can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Lorcaserin can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Lorcaserin can be decreased when it is combined with Bosentan.
Brexpiprazole
The serum concentration of Brexpiprazole can be increased when it is combined with Lorcaserin.
Bromocriptine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Bromperidol.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Lorcaserin.
Bupivacaine
The metabolism of Bupivacaine can be decreased when combined with Lorcaserin.
Buprenorphine
The metabolism of Buprenorphine can be decreased when combined with Lorcaserin.
Bupropion
Bupropion may increase the serotonergic activities of Lorcaserin.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Lorcaserin.
Cabergoline
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Cabergoline.
Caffeine
The metabolism of Lorcaserin can be decreased when combined with Caffeine.
Captopril
The metabolism of Captopril can be decreased when combined with Lorcaserin.
Carbamazepine
The metabolism of Lorcaserin can be increased when combined with Carbamazepine.
Cariprazine
The metabolism of Cariprazine can be decreased when combined with Lorcaserin.
Carteolol
The metabolism of Carteolol can be decreased when combined with Lorcaserin.
Carvedilol
The metabolism of Carvedilol can be decreased when combined with Lorcaserin.
Celecoxib
The metabolism of Lorcaserin can be decreased when combined with Celecoxib.
Cephalexin
The metabolism of Cephalexin can be decreased when combined with Lorcaserin.
CEPHALEXIN ANHYDROUS
The metabolism of Cephalexin can be decreased when combined with Lorcaserin.
Ceritinib
The serum concentration of Lorcaserin can be increased when it is combined with Ceritinib.
Cevimeline
The metabolism of Cevimeline can be decreased when combined with Lorcaserin.
Chloramphenicol
The metabolism of Lorcaserin can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The metabolism of Chlordiazepoxide can be decreased when combined with Lorcaserin.
Chloroquine
The metabolism of Lorcaserin can be decreased when combined with Chloroquine.
Chlorpheniramine
The metabolism of Chlorphenamine can be decreased when combined with Lorcaserin.
CHLORPHENIRAMINE POLISTIREX
The metabolism of Chlorphenamine can be decreased when combined with Lorcaserin.
Chlorpromazine
The metabolism of Lorcaserin can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Chlorprothixene.
Chlorzoxazone
The metabolism of Chlorzoxazone can be decreased when combined with Lorcaserin.
Cholecalciferol
The metabolism of Lorcaserin can be decreased when combined with Cholecalciferol.
Cilostazol
The metabolism of Cilostazol can be decreased when combined with Lorcaserin.
Cimetidine
The metabolism of Lorcaserin can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Lorcaserin can be decreased when combined with Cinacalcet.
Cinnarizine
The metabolism of Cinnarizine can be decreased when combined with Lorcaserin.
Citalopram
The risk or severity of adverse effects can be increased when Citalopram is combined with Lorcaserin.
Clarithromycin
The metabolism of Lorcaserin can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Lorcaserin can be decreased when combined with Clemastine.
Clevidipine
The metabolism of Clevidipine can be decreased when combined with Lorcaserin.
Clevidipine butyrate
The metabolism of Clevidipine can be decreased when combined with Lorcaserin.
Clobazam
The metabolism of Lorcaserin can be decreased when combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Lorcaserin.
Clonidine
The metabolism of Clonidine can be decreased when combined with Lorcaserin.
Clopidogrel
The metabolism of Lorcaserin can be decreased when combined with Clopidogrel.
Clotrimazole
The metabolism of Lorcaserin can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Lorcaserin can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Lorcaserin can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Lorcaserin can be decreased when combined with Cocaine.
Codeine
The therapeutic efficacy of Codeine can be decreased when used in combination with Lorcaserin.
Codeine Anhydrous
The therapeutic efficacy of Codeine can be decreased when used in combination with Lorcaserin.
CODEINE POLISTIREX
The therapeutic efficacy of Codeine can be decreased when used in combination with Lorcaserin.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Lorcaserin.
Crizotinib
The metabolism of Lorcaserin can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Lorcaserin can be decreased when combined with Curcumin.
Cyamemazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Cyamemazine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Lorcaserin.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Lorcaserin.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Lorcaserin.
Cyclosporine
The metabolism of Lorcaserin can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Lorcaserin can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Lorcaserin can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The metabolism of Dapagliflozin can be decreased when combined with Lorcaserin.
Dapiprazole
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Dapiprazole.
Darifenacin
The metabolism of Lorcaserin can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Lorcaserin can be increased when it is combined with Darunavir.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Lorcaserin.
Dasatinib
The serum concentration of Lorcaserin can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Lorcaserin can be increased when it is combined with Dasatinib.
Debrisoquin
The metabolism of Debrisoquin can be decreased when combined with Lorcaserin.
Deferasirox
The serum concentration of Lorcaserin can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Lorcaserin can be decreased when combined with Delavirdine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Lorcaserin.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Desvenlafaxine.
Deutetrabenazine
The metabolism of Deutetrabenazine can be decreased when combined with Lorcaserin.
Dexchlorpheniramine maleate
The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Lorcaserin.
Dexfenfluramine
The metabolism of Dexfenfluramine can be decreased when combined with Lorcaserin.
Dexmethylphenidate
The metabolism of Dexmethylphenidate can be decreased when combined with Lorcaserin.
Dextroamphetamine
The metabolism of Dextroamphetamine can be decreased when combined with Lorcaserin.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Lorcaserin.
Dihydrocodeine
The metabolism of Dihydrocodeine can be decreased when combined with Lorcaserin.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Dihydroergotamine.
Diltiazem
The metabolism of Lorcaserin can be decreased when combined with Diltiazem.
Diphenhydramine
The metabolism of Lorcaserin can be decreased when combined with Diphenhydramine.
Dipyridamole
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Dipyridamole.
Dolasetron
The metabolism of Dolasetron can be decreased when combined with Lorcaserin.
Domperidone
The metabolism of Domperidone can be decreased when combined with Lorcaserin.
Donepezil
The metabolism of Donepezil can be decreased when combined with Lorcaserin.
Dopamine
The metabolism of Dopamine can be decreased when combined with Lorcaserin.
Dothiepin
The metabolism of Lorcaserin can be decreased when combined with Dosulepin.
Doxazosin
The metabolism of Doxazosin can be decreased when combined with Lorcaserin.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Lorcaserin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Lorcaserin.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Lorcaserin.
Doxycycline
The metabolism of Lorcaserin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Lorcaserin can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Lorcaserin can be decreased when combined with Dronedarone.
Droperidol
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Droperidol.
Duloxetine
The risk or severity of adverse effects can be increased when Duloxetine is combined with Lorcaserin.
Efavirenz
The metabolism of Lorcaserin can be decreased when combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Lorcaserin.
Eliglustat
The serum concentration of Eliglustat can be increased when it is combined with Lorcaserin.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Lorcaserin.
Encainide
The metabolism of Encainide can be decreased when combined with Lorcaserin.
Enzalutamide
The serum concentration of Lorcaserin can be decreased when it is combined with Enzalutamide.
Epinastine
The metabolism of Epinastine can be decreased when combined with Lorcaserin.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Ergoloid mesylate.
Ergonovine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Ergonovine.
Ergotamine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Ergotamine.
Erlotinib
The metabolism of Erlotinib can be decreased when combined with Lorcaserin.
Erythromycin
The metabolism of Lorcaserin can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Escitalopram is combined with Lorcaserin.
Eslicarbazepine Acetate
The metabolism of Lorcaserin can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Lorcaserin can be decreased when combined with Esomeprazole.
Ethylmorphine
The metabolism of Ethylmorphine can be decreased when combined with Lorcaserin.
Etoricoxib
The metabolism of Etoricoxib can be decreased when combined with Lorcaserin.
Etravirine
The metabolism of Lorcaserin can be decreased when combined with Etravirine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Lorcaserin.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Lorcaserin.
Fingolimod
The metabolism of Fingolimod can be decreased when combined with Lorcaserin.
Flecainide
The metabolism of Flecainide can be decreased when combined with Lorcaserin.
Fluconazole
The metabolism of Lorcaserin can be decreased when combined with Fluconazole.
Flunarizine
The metabolism of Flunarizine can be decreased when combined with Lorcaserin.
Fluoxetine
The metabolism of Lorcaserin can be decreased when combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Flupentixol.
Fluphenazine
The metabolism of Fluphenazine can be decreased when combined with Lorcaserin.
Fluspirilene
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Fluspirilene.
Fluvastatin
The metabolism of Fluvastatin can be decreased when combined with Lorcaserin.
Fluvoxamine
The metabolism of Lorcaserin can be decreased when combined with Fluvoxamine.
Formoterol
The metabolism of Formoterol can be decreased when combined with Lorcaserin.
Fosamprenavir
The metabolism of Lorcaserin can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Lorcaserin can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Lorcaserin can be increased when combined with Fosphenytoin.
Fostamatinib
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Fostamatinib.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lorcaserin.
Fusidate
The serum concentration of Lorcaserin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Lorcaserin can be increased when it is combined with Fusidic Acid.
Galantamine
The metabolism of Galantamine can be decreased when combined with Lorcaserin.
Gefitinib
The metabolism of Gefitinib can be decreased when combined with Lorcaserin.
Gemfibrozil
The metabolism of Lorcaserin can be decreased when combined with Gemfibrozil.
Granisetron
The metabolism of Granisetron can be decreased when combined with Lorcaserin.
Halofantrine
The metabolism of Halofantrine can be decreased when combined with Lorcaserin.
Haloperidol
The metabolism of Lorcaserin can be decreased when combined with Haloperidol.
Halothane
The metabolism of Halothane can be decreased when combined with Lorcaserin.
Hydrocodone
The metabolism of Hydrocodone can be decreased when combined with Lorcaserin.
HYDROCODONE POLISTIREX
The metabolism of Hydrocodone can be decreased when combined with Lorcaserin.
Hydromorphone
The metabolism of Hydromorphone can be decreased when combined with Lorcaserin.
Hypoxis hemerocallidea root extract
The serum concentration of Lorcaserin can be decreased when it is combined with St. John's Wort.
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Lorcaserin.
Idarubicin
The metabolism of Idarubicin can be decreased when combined with Lorcaserin.
Idelalisib
The metabolism of Lorcaserin can be decreased when combined with Idelalisib.
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Lorcaserin.
Imatinib
The metabolism of Lorcaserin can be decreased when combined with Imatinib.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Lorcaserin.
Indinavir
The metabolism of Lorcaserin can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Lorcaserin can be decreased when combined with Indinavir.
Ipecac
The metabolism of Ipecac can be decreased when combined with Lorcaserin.
Ipratropium
The metabolism of Ipratropium bromide can be decreased when combined with Lorcaserin.
Ipratropium cation
The metabolism of Ipratropium bromide can be decreased when combined with Lorcaserin.
Isavuconazole
The serum concentration of Lorcaserin can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Lorcaserin can be decreased when combined with Isavuconazonium.
Isocarboxazid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Lorcaserin.
Isoniazid
The metabolism of Lorcaserin can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Lorcaserin can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Lorcaserin can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Lorcaserin can be increased when it is combined with Ivacaftor.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Lorcaserin.
Ketoconazole
The metabolism of Lorcaserin can be decreased when combined with Ketoconazole.
Labetalol
The metabolism of Labetalol can be decreased when combined with Lorcaserin.
Lamotrigine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Lamotrigine.
Letermovir
The metabolism of Letermovir can be decreased when combined with Lorcaserin.
Levodopa
The metabolism of Levodopa can be decreased when combined with Lorcaserin.
Levomilnacipran
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Levomilnacipran.
Lidocaine
The metabolism of Lorcaserin can be decreased when combined with Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Lorcaserin.
Lisuride
The metabolism of Lisuride can be decreased when combined with Lorcaserin.
Lithium
The risk or severity of adverse effects can be increased when Lithium is combined with Lorcaserin.
Lithium Cation
The risk or severity of adverse effects can be increased when Lithium is combined with Lorcaserin.
Lofexidine
The metabolism of Lofexidine can be decreased when combined with Lorcaserin.
Lomustine
The metabolism of Lomustine can be decreased when combined with Lorcaserin.
Loperamide
The metabolism of Loperamide can be decreased when combined with Lorcaserin.
Lopinavir
The metabolism of Lorcaserin can be decreased when combined with Lopinavir.
Loratadine
The metabolism of Loratadine can be decreased when combined with Lorcaserin.
Lovastatin
The metabolism of Lorcaserin can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Loxapine.
Luliconazole
The serum concentration of Lorcaserin can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Lorcaserin can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Lorcaserin can be decreased when combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Lurasidone.
Manidipine
The metabolism of Lorcaserin can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Lorcaserin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Lorcaserin.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Lorcaserin.
Mequitazine
The metabolism of Mequitazine can be decreased when combined with Lorcaserin.
Mesoridazine
The metabolism of Mesoridazine can be decreased when combined with Lorcaserin.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Lorcaserin.
Methamphetamine
The metabolism of Methamphetamine can be decreased when combined with Lorcaserin.
Methotrimeprazine
The metabolism of Lorcaserin can be decreased when combined with Methotrimeprazine.
Methoxyflurane
The metabolism of Methoxyflurane can be decreased when combined with Lorcaserin.
Methylergonovine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Methylergometrine.
Methylphenidate
The metabolism of Methylphenidate can be decreased when combined with Lorcaserin.
Methyprylon
The metabolism of Methyprylon can be decreased when combined with Lorcaserin.
Metoclopramide
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Metoclopramide.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Lorcaserin.
Metylperon
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Melperone.
Mexiletine
The metabolism of Lorcaserin can be decreased when combined with Mexiletine.
Mianserin
The metabolism of Mianserin can be decreased when combined with Lorcaserin.
Midostaurin
The metabolism of Lorcaserin can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Lorcaserin can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Milnacipran.
Minaprine
The metabolism of Minaprine can be decreased when combined with Lorcaserin.
Mirabegron
The metabolism of Mirabegron can be decreased when combined with Lorcaserin.
Mirtazapine
The risk or severity of adverse effects can be increased when Mirtazapine is combined with Lorcaserin.
Mitotane
The serum concentration of Lorcaserin can be decreased when it is combined with Mitotane.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Lorcaserin.
Modafinil
The metabolism of Lorcaserin can be decreased when combined with Modafinil.
Molindone
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Molindone.
Morphine
The metabolism of Morphine can be decreased when combined with Lorcaserin.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Lorcaserin.
Nateglinide
The metabolism of Nateglinide can be decreased when combined with Lorcaserin.
Nebivolol
The serum concentration of Nebivolol can be increased when it is combined with Lorcaserin.
Nefazodone
The metabolism of Lorcaserin can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Lorcaserin can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Lorcaserin can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Lorcaserin can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Lorcaserin can be decreased when combined with Nicardipine.
Nicergoline
The metabolism of Nicergoline can be decreased when combined with Lorcaserin.
Nicotine
The metabolism of Nicotine can be decreased when combined with Lorcaserin.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Lorcaserin.
Nifedipine
The metabolism of Nifedipine can be decreased when combined with Lorcaserin.
Nilotinib
The metabolism of Lorcaserin can be decreased when combined with Nilotinib.
Nitrofurazone
The metabolism of Nitrofural can be decreased when combined with Lorcaserin.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Lorcaserin.
Olanzapine
The metabolism of Olanzapine can be decreased when combined with Lorcaserin.
Olaparib
The metabolism of Lorcaserin can be decreased when combined with Olaparib.
Omeprazole
The metabolism of Lorcaserin can be decreased when combined with Omeprazole.
Ondansetron
The metabolism of Ondansetron can be decreased when combined with Lorcaserin.
Opium
The metabolism of Opium can be decreased when combined with Lorcaserin.
Osimertinib
The serum concentration of Lorcaserin can be increased when it is combined with Osimertinib.
Oxycodone
The metabolism of Oxycodone can be decreased when combined with Lorcaserin.
Oxymorphone
The metabolism of Oxymorphone can be decreased when combined with Lorcaserin.
Palbociclib
The serum concentration of Lorcaserin can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Paliperidone.
Palonosetron
The metabolism of Palonosetron can be decreased when combined with Lorcaserin.
Panobinostat
The serum concentration of Lorcaserin can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Lorcaserin can be decreased when combined with Pantoprazole.
Paregoric
The metabolism of Morphine can be decreased when combined with Lorcaserin.
Paroxetine
The metabolism of Lorcaserin can be decreased when combined with Paroxetine.
Pazopanib
The metabolism of Pazopanib can be decreased when combined with Lorcaserin.
Peginterferon Alfa-2b
The serum concentration of Lorcaserin can be decreased when it is combined with Peginterferon alfa-2b.
Pentamidine
The metabolism of Pentamidine can be decreased when combined with Lorcaserin.
Pentobarbital
The metabolism of Lorcaserin can be increased when combined with Pentobarbital.
Pentoxifylline
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Pentoxifylline.
Perazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Perazine.
Perhexiline
The metabolism of Perhexiline can be decreased when combined with Lorcaserin.
Periciazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Propericiazine.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Lorcaserin.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Lorcaserin.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Lorcaserin.
Phenformin
The metabolism of Phenformin can be decreased when combined with Lorcaserin.
Phenobarbital
The metabolism of Lorcaserin can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Lorcaserin can be increased when combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Pimozide.
Pindolol
The metabolism of Pindolol can be decreased when combined with Lorcaserin.
Pipamperone
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Pipamperone.
Piperazine
The metabolism of Piperazine can be decreased when combined with Lorcaserin.
Pipothiazine
The metabolism of Pipotiazine can be decreased when combined with Lorcaserin.
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Lorcaserin.
Posaconazole
The metabolism of Lorcaserin can be decreased when combined with Posaconazole.
Primidone
The metabolism of Lorcaserin can be increased when combined with Primidone.
Procainamide
The metabolism of Procainamide can be decreased when combined with Lorcaserin.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Lorcaserin.
Prochlorperazine
The metabolism of Prochlorperazine can be decreased when combined with Lorcaserin.
Progesterone
The metabolism of Progesterone can be decreased when combined with Lorcaserin.
Promazine
The metabolism of Lorcaserin can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Lorcaserin.
Propafenone
The serum concentration of Lorcaserin can be increased when it is combined with Propafenone.
Propofol
The metabolism of Propofol can be decreased when combined with Lorcaserin.
Propranolol
The metabolism of Propranolol can be decreased when combined with Lorcaserin.
Prothipendyl
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Lorcaserin.
Pseudoephedrine
The metabolism of Pseudoephedrine can be decreased when combined with Lorcaserin.
Quazepam
The serum concentration of Lorcaserin can be increased when it is combined with Quazepam.
Quetiapine
The metabolism of Quetiapine can be decreased when combined with Lorcaserin.
Quetiapine fumarate
The metabolism of Quetiapine can be decreased when combined with Lorcaserin.
Quinidine
The metabolism of Lorcaserin can be decreased when combined with Quinidine.
Quinine
The metabolism of Lorcaserin can be decreased when combined with Quinine.
Ranitidine
The metabolism of Ranitidine can be decreased when combined with Lorcaserin.
Ranolazine
The metabolism of Lorcaserin can be decreased when combined with Ranolazine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Lorcaserin.
Remoxipride
The metabolism of Remoxipride can be decreased when combined with Lorcaserin.
Reserpine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Reserpine.
Rifabutin
The metabolism of Lorcaserin can be increased when combined with Rifabutin.
Rifampin
The metabolism of Lorcaserin can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Lorcaserin can be increased when combined with Rifapentine.
Risperidone
The metabolism of Risperidone can be decreased when combined with Lorcaserin.
Ritonavir
The metabolism of Lorcaserin can be decreased when combined with Ritonavir.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Lorcaserin.
Rolapitant
The metabolism of Lorcaserin can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Lorcaserin can be decreased when combined with Ropinirole.
Ropivacaine
The metabolism of Ropivacaine can be decreased when combined with Lorcaserin.
Rotigotine
The metabolism of Rotigotine can be decreased when combined with Lorcaserin.
Rucaparib
The metabolism of Rucaparib can be decreased when combined with Lorcaserin.
Saquinavir
The metabolism of Lorcaserin can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Lorcaserin can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Lorcaserin can be decreased when used in combination with Sarilumab.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Lorcaserin.
Sertindole
The metabolism of Sertindole can be decreased when combined with Lorcaserin.
Sertraline
The risk or severity of adverse effects can be increased when Sertraline is combined with Lorcaserin.
Sildenafil
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Sildenafil.
Siltuximab
The serum concentration of Lorcaserin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Lorcaserin can be increased when it is combined with Simeprevir.
Simvastatin
The metabolism of Simvastatin can be decreased when combined with Lorcaserin.
Sorafenib
The metabolism of Lorcaserin can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Lorcaserin can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Lorcaserin can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lorcaserin.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lorcaserin.
Tadalafil
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Tadalafil.
Tamoxifen
The serum concentration of the active metabolites of Tamoxifen can be reduced when Tamoxifen is used in combination with Lorcaserin resulting in a loss in efficacy.
Tamsulosin
The metabolism of Tamsulosin can be decreased when combined with Lorcaserin.
Tapentadol
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Tapentadol.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Lorcaserin.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Lorcaserin.
Tegaserod
The metabolism of Tegaserod can be decreased when combined with Lorcaserin.
Telaprevir
The metabolism of Lorcaserin can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Lorcaserin can be decreased when combined with Telithromycin.
Tenofovir Disoproxil
The metabolism of Lorcaserin can be decreased when combined with Tenofovir disoproxil.
Terbinafine
The metabolism of Lorcaserin can be decreased when combined with Terbinafine.
Terfenadine
The metabolism of Terfenadine can be decreased when combined with Lorcaserin.
Teriflunomide
The serum concentration of Lorcaserin can be decreased when it is combined with Teriflunomide.
Tetrabenazine
The metabolism of Tetrabenazine can be decreased when combined with Lorcaserin.
Theophylline
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Theophylline.
Theophylline anhydrous
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Theophylline.
Thioproperazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Thioproperazine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Lorcaserin.
Thiotepa
The metabolism of Lorcaserin can be decreased when combined with Thiotepa.
Thiothixene
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Thiothixene.
Tiapride
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Tiapride.
Ticlopidine
The metabolism of Lorcaserin can be decreased when combined with Ticlopidine.
Timolol
The metabolism of Timolol can be decreased when combined with Lorcaserin.
Timolol Anhydrous
The metabolism of Timolol can be decreased when combined with Lorcaserin.
Tiotropium
The metabolism of Tiotropium can be decreased when combined with Lorcaserin.
Tipranavir
The metabolism of Lorcaserin can be decreased when combined with Tipranavir.
Tocilizumab
The serum concentration of Lorcaserin can be decreased when it is combined with Tocilizumab.
Tolterodine
The metabolism of Tolterodine can be decreased when combined with Lorcaserin.
Topiramate
The metabolism of Lorcaserin can be decreased when combined with Topiramate.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Lorcaserin.
Tramadol
The therapeutic efficacy of Tramadol can be decreased when used in combination with Lorcaserin.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Lorcaserin.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Lorcaserin.
Trifluoperazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Lorcaserin.
Tropisetron
Tropisetron may increase the serotonergic activities of Lorcaserin.
Umeclidinium
The metabolism of Umeclidinium can be decreased when combined with Lorcaserin.
Valbenazine
The metabolism of Valbenazine can be decreased when combined with Lorcaserin.
Vardenafil
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Vardenafil.
Vemurafenib
The serum concentration of Lorcaserin can be increased when it is combined with Vemurafenib.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lorcaserin.
Verapamil
The metabolism of Lorcaserin can be decreased when combined with Verapamil.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Lorcaserin.
Vinblastine
The metabolism of Vinblastine can be decreased when combined with Lorcaserin.
Vinorelbine
The metabolism of Vinorelbine can be decreased when combined with Lorcaserin.
Voriconazole
The metabolism of Lorcaserin can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lorcaserin.
Yohimbine
The metabolism of Yohimbine can be decreased when combined with Lorcaserin.
Zalcitabine
The metabolism of Zalcitabine can be decreased when combined with Lorcaserin.
Ziprasidone
The metabolism of Lorcaserin can be decreased when combined with Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lorcaserin.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Lorcaserin.
Zotepine
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Zotepine.
Zuclopenthixol
The metabolism of Zuclopenthixol can be decreased when combined with Lorcaserin.
